Talking With Docs on MSN

Kneeling ability after total knee replacement surgery

'Taylor Swift is a Nazi' narrative boosted by coordinated online effort, new report finds Michigan fires head coach Sherrone ...

'Huge win' — Windsor private clinic welcomes provincial hip, knee replacement surgery funding

Some private clinics in Ontario, including Windsor’s, have offered optional upgrades for cataract surgery at an additional ...
Medical Design & Outsourcing

How Zimmer Biomet brought an advanced material tech to revision knee surgeries

Cristina Piecuch explains how Zimmer Biomet used its Tivanium alloy to create an alternative for knee patients with nickel ...
Healio

Retatrutide confers up to 28.7% weight loss, reduction in knee osteoarthritis pain

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

Cowboys Star Emerges as Potential Travis Kelce Replacement

Kansas City tight end Travis Kelce, who had seven catches for 70 yards against the Chargers, is in the final year of his ...
TMCnet

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Clinical Development Program Appropriate for Rolling BLA . Submission Expected by the End of 2025. CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Na ...

Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial

Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...
ConsumerAffairs

Lilly reports promising results from its weight-loss drug trial

Eli Lilly’s experimental weight-loss drug retatrutide led to an average weight reduction of up to 28.7%—more than 71 ...

Lilly reports solid results from new weight-loss drug trial

Eli Lilly reported the first successful phase three results for retatrutide, its experimental once-weekly ‘triple agonist’ ...

Aston Villa vs. United: Predicted line-up as Amorim switches to four at the back

Manchester United head coach Ruben Amorim could be forced to change his preferred three-at-the-back formation for Sunday’s ...

Organogenesis Holdings Inc.: Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu for Knee Osteoarthritis Pain

Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading ...